Plant Summary

  Plant Information

TCMBank_ID:

TCMBANKHE006400

ID:

TCMBANKHE006400

植物拉丁名:

Semen Cucurbitae moschatae
显示图片

功能与主治:

To kill parasites/Taeniasis, ascariasis, bilharziosis, ancylostomiasis, oxyuria disease, postpartum scant milk, postpartum edema, pertussis, hemorrhoids.

药用植物名:

南瓜子

药用部位:

seed

药味:

Sweet; neutral

经络:

Stomach; large intestine

临床特征:

1. Synergetic with Arecae for tapeworm infection. 2. Cucurbitine, one of its components, is schistosomicidal.

治疗类型:

驱虫药

TCM_ID_id:

2697

SymMap_id:

295

TCMSP_id:

1013

   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN000029 colchicine LS-187917 C22H25NO6 399.44 CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC
TCMBANKIN001719 lecithin phosphatidylcholine; 1-Lignoceryl-2-eicsoic acid; 1-Lignoceryl-2-eicsoate; 1-Lignoceryl-2-eicsoatetraenoyl-sn-glycero-3-phosphocholine C52H98NO7P 880.3 g/mol CCCCCCCCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC
TCMBANKIN005253 3-OCTENOIC ACID 1577-19-1; trans-beta-octenoic acid; oct-3-enoic acid; EINECS 216-418-3; (E)-Oct-3-enoic acid; trans-3-octenoic acid; 3E-octenoic acid; LMFA01030020; EINECS 225-941-6; 5163-67-7 C8H14O2 142.2 CCCCC=CCC(=O)O
TCMBANKIN007284 3,5-Octadien-2-one, (E,E)- 3,5-Octadien-2-one; 3,5-Octadien-2-one, #2; (3E,5E)-octa-3,5-dien-2-one; 3,5-Octadien-2-one #1; 38284-27-4; (3E,5E)-3,5-Octadien-2-one C8H12O 124.18 CCC=CC=CC(=O)C
TCMBANKIN008084 Daturic acid 67701-03-5; daturicacid; n-Heptadecylic acid; EINECS 266-928-5; 51610_FLUKA; 67255-22-5; 68424-37-3; NSC3743; (C16-C18)Alkylcarboxylic acid; WLN: QV16; NSC 3743; SDA 19-005-00; 8043-36-5; CH3-[CH2]15-COOH; EINECS 264-123-3; 506-12-7; LMFA01010017; AI3-36481; EINECS 208-027-1; Lead(2+) heptadecanoate; 37231-04-2; Margaric acid; 45237-52-3; n-Heptadecanoic acid; 7722-21-6; 63399-94-0; Heptadecylic acid; n-Heptadecoic acid; 39390-60-8; heptadecoic acid; 8000-11-1; (C16-C18) Alkylcarboxylic acid; daturic acid; C14-C22 Fatty acid residue; Heptadecanoic acid; Margarinsaeure; 8034-57-9; CHEBI:32365; Fatty acids, C14-22; 28829-31-4; 8034-58-0; 1338-46-1; 52051-63-5; EINECS 270-298-7; 8034-56-8; 4-02-00-01193 (Beilstein Handbook Reference); Fatty acids, C16-18; BRN 1781004; 176435-16-8; 45237-51-2; H3500_SIGMA; Margarinic acid C17H34O2Pb 478 g/mol CCCCCCCCCCCCCCCCC(=O)O.[Pb]
TCMBANKIN008877 PKA Plaskon XP 607; Itamide 25; PK 4; Bonamid; Capron; Nylon A1035SF; NSC8437; Capron B; Extron 6N; Amilan CM 1001C; Plaskon 8252; Nylon CM 1031; Kapromin; Durethan BK; B-35; 6-Aminohexanoic acid homopolymer; 4-02-00-00929 (Beilstein Handbook Reference); 25038-54-4; B-350; Ultramid BMK; Polycaprolactam; B-203; Capron GR 8257; Grilon; Zytel 211; Tarnamid T; Amilan CM 1001G; Chemlon; Capron 8256; TNK 2G5; Kapron B; Durethan BKV 30H; B-216; Hexanoamide; epsilon-Caprolactam polymere [German]; Plaskon 201; DULL 704; Itamide 35; CM 1001; BRN 1741923; CM 1041; Tarlon X-A; Polycaproamide; B-300; Kaprolon B; Nylon-6; Kaprolit B; Nylon; Plaskin 8200; Kapron; Nylon 6; A 1030N0; CCRIS 4822; Orgamid rmnocd; Spencer 401; Spencer 601; Capronamide; Itamide 250G; Tarlon XB; Miramid WM 55; Alkamid; Maranyl F 500; 628-02-4; Caproamide; Itamid 250; Kapron A; Sipas 60; Poly(imino(1-oxo-1,6 hexanediyl)); Poly(iminocarbonylpentamethylene); NSC 8437; Vidlon; Capran 77C; epsilon-Caprolactam polymer; Miramid H 2; POLY(IMINO(1-OXO-1,6-HEXANEDIYL)); Akulon; Ultramid B 4; Poly(epsilon-aminocaproic acid); Renyl MV; Itamide 250; UBE 1022B; Akulon M 2W; Plaskon 8205; Caprolactam oligomer; Ertalon 6SA; PA 6 (Polymer); CM 1011; Capron PK 4; Capron GR 8256; Plaskon 8201HS; Tarnamid T 2; Orgamide; NCI-C02142; Capron 8253; Caprolon V; Widlon; A 1030; Ultramid B 3; Caprolon B; Hexahydro-2H-azepin-2-one homopolymer; Plaskon 8207; Plaskon 8202C; Capron 8252; Nylon X 1051; Ultramid B 5; Plaskon 8201; Poly(hexahydro-2H-azepin-2-one); Policapramum [INN-Latin]; Hexanamide; 293393_ALDRICH; Capron 8250; NCGC00091313-01; Capran 80; Relon P; Torayca N 6; Durethan BK 30S; Tarpamid T 27; Maranyl F 114; P 6 (Polyamide); EINECS 211-024-8; AI3-19495; Durethan BKV 55H; Kaprolon; Polyamide 6; KS 30P; n-Caproamide; Danamid; Metamid; n-Hexanamide; Amilan CM 1001; Capron GR 8258; Hexamide (VAN); Itamid; ATM 2 (nylon); CM 1031; Caprolactam polymer; Policapran; Maranyl F 124; Itamide 350; ZINC01586742; HSDB 5509; Hexamide; Policapram [USAN:INN]; Kaprolit; Amilan CM 1031; Hexylamide; Caproamide polymer; Itamide S; Aviamide-6; Amilan CM 1011 C6H13NO 115.17 [CH]CCCCC(=O)[N]
TCMBANKIN008882 phosphatidyl ethanolamine phosphatidylethanolamine 716.11 CCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[NH3+])OC(=O)CCCCCCCCCCC
TCMBANKIN009674 2-Hexynoic acid NSC289569; 764-33-0; SBB009091; 662895_ALDRICH; hex-2-ynoic acid C6H8O2 112.13 CCCC#CC(=O)O
TCMBANKIN014909 Dioctadecanoylphosphatidylserine L-Serine, 2,3-bis[(1-oxooctadecyl)oxy]propyl ester, dihydrogen phosphate (ester), (R)-; (2S)-2-amino-3-[[(2R)-2,3-bis(1-oxooctadecoxy)propoxy]-hydroxyphosphoryl]oxypropanoic acid; PS(18:0/18:0); (2S)-2-amino-3-[[(2R)-2,3-di(octadecanoyloxy)propoxy]-hydroxy-phosphoryl]oxy-propanoic acid; (2S)-2-amino-3-[[(2R)-2,3-distearoyloxypropoxy]-hydroxy-phosphoryl]oxy-propionic acid; LMGP03010036; (2S)-2-amino-3-[[(2R)-2,3-di(octadecanoyloxy)propoxy]-hydroxyphosphoryl]oxypropanoic acid C42H82NO10P 792.07 CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCCCCCCCCCCC
TCMBANKIN015886 (6Z,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene C30H50 410.72
TCMBANKIN017221 linoleic acid (9E,12E)-octadeca-9,12-dienoate; AC1NYW3V; sodium (9E,12E)-octadeca-9,12-dienoate; BDBM22336; 9,12-octadecadienoate; linoleicacid C18H31O2- 279.4 g/mol CCCCCC=CCC=CCCCCCCCC(=O)[O-]
TCMBANKIN018833 Triglyzerid CHEBI:17855; triglycerides; Triglyceride; 1,3-diformyloxypropan-2-yl formate; 1,3-dimethanoyloxypropan-2-yl methanoate; Triglycerid; triacylglycerols; [2-formyloxy-1-(formyloxymethyl)ethyl] formate; formic acid [2-formyloxy-1-(formyloxymethyl)ethyl] ester C9H12O9 264.19 g/mol C(C1C(=O)OC(C(=O)OC(C(=O)O1)CO)CO)O
TCMBANKIN023242 (1S,2R)-2-methylcyclopentanol (1S,2R)-2-methylcyclopentan-1-ol; InChI=1/C6H12O/c1-5-3-2-4-6(5)7/h5-7H,2-4H2,1H3/t5-,6+/m1/s; cyclopentanol, 2-methyl-, (1S,2R)-; (1S,2R)-2-methyl-1-cyclopentanol; ZINC02014257 C6H12O 100.16 CC1CCCC1O
TCMBANKIN025538 colchine (R/S)-Colchicine; MLS001181527; HMS3267B14; NE55304; I06-0591; CCG-46868; MCULE-7902106432; DTXSID20274387; ST056390; IAKHMKGGTNLKSZ-UHFFFAOYSA-N; 064T868; SMR000567246; KSC621O9T; HMS2875H17; C22H25NO6; CC0177; AC1Q5ODH; TR-031757; (+/-)-Colchicine; FT-0665155; Benzo[a]heptalen-9(5H)-one,7-acetamido-6,7-dihydro-1,2,3,10-tetramethoxy-; NCGC00094629-04; NCGC00094629-05; N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide #; Epitope ID:141498; Neuro_000002; AC-281; M205; BRD-A46684810-001-04-6; SCHEMBL675246; KB-295593; J-013744; BC216204; AB00830494-06; CHEBI:23359; Acetamide,N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]-; MFCD00078484; Colchine; N-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0(2),]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}acetamide; CTK5C1799; NCGC00094629-03; N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl)-acetamide; 209810-38-8; N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide; Z1431321925; AKOS016374434; N-{3,4,5,14-TETRAMETHOXY-13-OXOTRICYCLO[9.5.0.0(2),?]HEXADECA-1(16),2,4,6,11,14-HEXAEN-10-YL}ACETAMIDE; AKOS003381878; MolPort-001-785-612; N-((7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7-trihydrobenzo[d]heptalen-7-yl)acetam ide; DB01394; NCGC00094629-01; NCGC00094629-06; AS-14691; 16416P; N-(1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide; N-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0;{2,7}]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}acetamide; BBL010108; N-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0^{2,7}]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}acetamide; NCGC00094629-02; SBB079703; SR-01000636539-1; 54192-66-4; N-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0?,?]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}acetamide; (S)-Colchicine >95%; STK801462; 1,2,3,10-Tetramethoxy-7-(acetylamino)-5,6,7,9-tetrahydrobenzo[a]heptalene-9-one; AC1L1EKN; CHEMBL87; N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7-trihydrobenzo[d]heptalen-7-yl)acetamide; KB-86571 C22H25NO6 399.4 g/mol CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC
TCMBANKIN025988 LEUCINOL 2-METHYL-BUTYLAMINE; (2S)-2-methylbutan-1-amine; [(2S)-2-methylbutyl]amine; 241407_ALDRICH; 66139_FLUKA; (S)-(−)-2-Methyl-1-butylamine; (S)-(−)-2-Methylbutylamine; (S)-1-Amino-2-methylbutane C5H13N 87.16 CCC(C)CN
TCMBANKIN032965 Sphingoid Bio1_000803; Bio2_000726; NCGC00024697-03; KBio3_000491; C00319; (E,2S,3R)-2-aminooctadec-4-ene-1,3-diol; Bio2_000246; erythro-4-Sphingenine; 85621_FLUKA; D-(+)-erytho-4-trans-Sphingenine; CHEBI:26743; 4-Octadecene-1,3-diol, 2-amino-, (R-(R*,S*-(E)))-; 4-Octadecene-1,3-diol, 2-amino-, (R-(R*,S*-(E))); NCGC00024697-06; BSPBio_001526; (2S,3R,4E)-2-amino-4-octadecene-1,3-diol; Bio1_001292; 4-trans-Sphingenine; KBioGR_000246; SMP1_000277; trans-4-sphingenine; 4-Octadecene-1,3-diol, 2-amino-, (E)-D-erythro- (8CI); (E)-2-Amino-4-octadecan-1,3-diol; 4-Octadecene-1,3-diol, 2-amino-, (2S,3R,4E)- (9CI); Lopac0_001049; IDI1_033996; NCGC00024697-05; G-1251; 4-octadecene-1,3-diol, 2-amino-, (2S,3R,4E)-; D-erythro-Sphingosine; CCRIS 6899; 2-Aminooctadec-4-ene-1,3-diol; KBio2_002814; (2S,3R)-2-aminooctadec-4-ene-1,3-diol; KBio3_000492; BiomolKI2_000042; 4-Sphingenine; (4E)-sphing-4-enine; (2S,3R)-Sphingosine; (4E)-sphingenine; D-erythro-C18-Sphingosine; KBioSS_000246; C18-Sphingosine; erythro-C18-Sphingosine; (-)-D-erythro-Sphingosine; (2S,3R,4E)-2-aminooctadec-4-ene-1,3-diol; S7049_SIGMA; Erythrosphingosine; D-Sphingosine; trans-D-erythro-2-amino-4-octadecene-1,3-diol; Sphing-4-enine; 123-78-4; KBio2_000246; LMSP01010001; KBio2_005382; CBiol_002028; D-<i>erythro-</i>Sphingosine, Free Base, High Purity; 4-Octadecene-1,3-diol, 2-amino-, [R-[R*,S*-(E)]]-; EINECS 204-651-3; Bio1_000314; BiomolKI_000034; CHEBI:16393 C18H37NO2 299.49 CCCCCCCCCCCCCC=CC(C(CO)N)O
TCMBANKIN035864 Valeramide LMFA08010002; 42861-33-6; AI3-24387; Pentanamide; NSC 400223; ZINC01529296; C01842; CHEBI:16459; N-VALERAMIDE; NSC400223; FR-0155; Pentanimidic acid; EINECS 210-974-0; 626-97-1 C5H11NO 101.15 CCCCC(=O)N
TCMBANKIN036901 myristic acid 1-Tridecanecarboxylic acid; Myristinsaeure; CH3-[CH2]12-COOH; 70079_FLUKA; AI3-15381; LMFA01010014; CH3-[CH2]12-COO(-); NCGC00091068-02; Myristic acid-[9,10-3H]; C06424; Emery 655; myristic acid ; NSC 5028; 70082_FLUKA; C14 fatty acid; ST023797; W276405_ALDRICH; CCRIS 4724; Kortacid 1499; 3uev; TUNFSRHWOTWDNC-UHFFFAOYSA-M; Tetradecanoic acid; EINECS 250-924-5; n-Tetradecoic acid; 4-02-00-01126 (Beilstein Handbook Reference); Hydrofol acid 1495; MYR; BRN 0508624; Myristate; Myristic acid (natural); Tetradecanoate; LS-190125; Crodacid; Myristic acid (8CI); EINECS 208-875-2; Prifac 2942; Myristic acid; AIDS002505; tetradecoate; W276413_ALDRICH; FEMA No. 2764; HSDB 5686; Philacid 1400; CHEBI:28875; Edenor C 14; n-tetradecoate; 45184-05-2; myristicacid; tetradecoic acid; n-Tetradecanoic acid; M3128_SIGMA; AIDS-002505; Univol U 316S; Lead dimyristate; AC1N2PSK; NCGC00091068-01; neo-Fat 14; NSC5028; Tetradecanoic acid (9CI); Hystrene 9014; Myristic acid, pure; M4792_SIGMA; CHEBI:30807; n-Tetradecan-1-oic acid; WLN: QV13; 1-tetradecanecarboxylate; 32112-52-0; n-tetradecan-1-oate; 544-63-8 C14H28O2 228.371 C([H])([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]
TCMBANKIN039554 hexanoic acid (C6-C12) Alkylcarboxylic acid; n-Hexoic acid; BRN 0773837; Hexanoyl DL-carnitine; AC1O52RE; hexanoicacid; 142-62-1; Hexanoic acid (natural); n-Hexanoic acid; CCRIS 1347; Hexacid 698; 153745_ALDRICH; Hexanoic acid; 13476-79-4; 8040-17-3; 51109-46-7; AI3-07701; WLN: QV5; VVPRQWTYSNDTEA-UHFFFAOYSA-N; 19455-00-6; (C5-C9) Monobasic acids; Pentylformic acid; Hexanoyl-d,l-carnitine; Capronic acid; Butylacetic acid; Kyselina kapronova [Czech]; 4-02-00-00917 (Beilstein Handbook Reference); C01585; 1-Pentanecarboxylic acid; UN2829; 3-hexanoyloxy-4-(trimethylazaniumyl)butanoate; Fatty acids, C6-12; (C6-C12)Alkylcarboxylic acid; W255912_ALDRICH; NSC8266; CAPROIC ACID; CH3-[CH2]4-COOH; LMFA01010006; HEXANOIC ACID (CAPROIC ACID); n-Caproic acid; EINECS 267-013-3; CHEBI:30776; Hexanoylcarnitine; 68603-84-9; 70248-25-8; 21529_FLUKA; HSDB 6813; 3-(hexanoyloxy)-4-(trimethylazaniumyl)butanoate; Carboxylic acids, C5-9; NSC 8266; NCIOpen2_005355; LMFA07070070; 1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxohexyl)oxy]-, chloride (1:1); EINECS 205-550-7; SCHEMBL235082; 1-Hexanoic acid; Pentanecarboxylic acid; Acid C-6; Carboxylic acids, C6-18 and C6-18-unsatd. mono- and C8-15-di-; H12137_ALDRICH; W255904_ALDRICH; 16571-42-9; Hexylic acid; AIDS212980; Caproic acid [UN2829] [Corrosive]; FEMA No. 2559; 67762-36-1; n-Hexylic acid; Hexoic acid; Pentiformic acid; EINECS 274-509-3; 6418-78-6; AIDS-212980; 53896-26-7; CTK4C6070; EINECS 271-676-4; Hexanoic acid ester with (3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt; CHEBI:70749; InChI=1/C6H12O2/c1-2-3-4-5-6(7)8/h2-5H2,1H3,(H,7,8; O-hexanoylcarnitine; 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-[(1-oxohexyl)oxy]-, inner salt; 3-(hexanoyloxy)-4-(trimethylammonio)butanoate C6H12O2 116.158 C(O[H])(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]
TCMBANKIN041272 stearic acid 4-02-00-01206 (Beilstein Handbook Reference); AIDS-049230; Emersol 871; 8039-52-9; 126539-56-8; stearic acid, ion(1-); D00119; octadecoic acid; Hydrofol Acid 150 (VAN); 134503-33-6; Fatty acids C16-18; 68937-76-8; Kam 2000; VLZ 200; Lunac S 98; Glycon S-80; Hy-phi 1205; Lunac YA; Pristerene 9429; Pristerene 4900; Octadecanoic acid (9CI); Hystrene 9718NF; Edenor FHTI; Cetylacetic acid; NAA 173; NSC 25956; Lunac S 90; S 30C S 30C (fatty acid); Neo-Fat 18-61; Dar-chem 14; NSC25956; Edenor HT-JG 60; Octadecanoate; 57485-56-0; Oktadekansaeure; S 300 (fatty acid); Unister NAA 180; Industrene 5016; Prisorine 3508; Hydrofol Acid 150; Hystrene 4516; G 270; Stearic Acid Cherry; Century 1230; 822-16-2 (SODIUM SALT); NCGC00091596-02; Glycon S-90; 85404-83-7; NCGC00091596-01; Stearic acid (JP15/NF); Hystrene 5016; Hy-phi 1303; Glycon S-70; C01530; Octadecansaeure; Neo-Fat 18-55; WO 2 (fatty acid); Pristerene 9559; SA 200; Century 1240; Stearic acid, pure; Sunfat 18S; WO 2; CHEBI:28842; Industrene 5016K; LS-2392; Kam 3000; BRN 0608585; Edenor ST 20; AIDS049230; Lunac 30; EINECS 273-087-8; Emersol 150; 175366_SIAL; 8039-54-1; Fatty acids, C16-20; stearicacid; Stearic acid ion(1-)salt; Stearic acid (8CI); Stearinsaeure; Emersol 153NF; Hydrofol acid 1855; 57-11-4; Lunac S 30; Hystrene T 70; Prisorine 3501; Haimaric MKH(R); Stearex Beads; Groco 55; Hystrene S-97; Neo-Fat 18-54; W303518_ALDRICH; Hydrofol acid 1655; Nonsoul SN 1 (*Sodium salt*); EINECS 200-313-4; 39390-61-9; Emersol 120; EPA Pesticide Chemical Code 079082; Lunac S 20; Octadecanoic acid, ion(1-); 8013-28-3; AI3-00909; Kortacid 1895; FEMA No. 3035; Hystrene S 97; 82497-27-6; Tegostearic 254; SNA-2000 (*Sodium salt*); 1-Heptadecanecarboxylic acid; AC1MHWEJ; STL280244; 27405_RIEDEL; Steric acid; Industrene 9018; Glycon dp; F 3 (lubricant); Hy-phi 1401; Lunac S 50; Emersol 132; Stearic acid, ion(1-) (8CI); CH3-[CH2]16-COO(-); acide octadecanoique; Groco 55l; 73297_FLUKA; Serfax MT 90; Stearic acid [USAN:JAN]; 8039-51-8; acide stearique; Kam 1000; Acidum stearinicul; InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20; 8039-53-0; 17FA; Stearophanic acid; 8037-83-0; Hystrene 7018; FA 1655; Prisorine 3502; Nonsoul SK 1; Hydrofol Acid 1895; Lunac S 40; Stearic acid 50; 8023-06-1; 85679_FLUKA; HSDB 2000; n-Octadecanoate; 400JB9103-88; Glycon tp; Unimac 5680; Loxiol G 20; Stearate; 875D; Octadecanoic acid; Neo-Fat 18-53; octadecanoate (n-C18:0); Radiacid 0427; Emery 871; Vanicol; Vis-Plus; PD 185; EINECS 250-178-0; AKOS022105769; 646-29-7; Edenor ST 1; S 300; Caswell No. 801D; Selosol 920; Tegostearic 272; Isostearic acid EX; A 1760; WLN: QV17; Stearic acid (TN); Pearl stearic; 609343-71-7; Palmitic acid - stearic acid mixture; Emersol 875; Industrene 8718; Hystrene 9718NFFG; NCGC00164255-02; ST023799; LMFA01010018; Groco 54; Edenor C18; Hystrene T-70; Hy-phi 1199; CTK8J8420; n-Octadecanoic acid; Groco 58; Pristerene 4963; Formula 300; AFCO-Chem B 65; CCRIS 2305; Industrene R; Century 1220; S4751_SIGMA; Neo-Fat 18; 58392-66-8; Barolub FTA; Hystrene 9718; CH3-[CH2]16-COOH; STE; 8037-40-9; 30399-84-9; Lunac S 90KC; Hydrofol 1895; Emery 875D; Century 1210; QIQXTHQIDYTFRH-UHFFFAOYSA-M; Neo-Fat 18-59; LS-1388; Groco 59; Humko Industrene R; Hystrene 80; Adeka Fatty Acid SA 910; Stearic acid; Prifac 2918; Emersol 6349; Edenor C 18/98; 3uex; LS-97707; CHEBI:25629; Neo-Fat 18-S; Stearic acid - palmitic acid mixture; Tegostearic 255; C-Lube 10 C18H36O2 284 C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])= O
TCMBANKIN041568 cucurbitoside e C24H28O12 508.5 g/mol C1C(C(C(O1)OC2C(C(C(OC2OC3=CC=C(C=C3)O)CO)O)O)O)(COC(=O)C4=CC=CC=C4)O
TCMBANKIN043968 Cucurbitoside D C25H30O13 538 c1([H])c([H])c(C(=O)OC([H])([H])[C@@]2([C@]([H])([C@@]([H])(OC2([H])[H])O[C@]([H])([C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O3)[C@]3([H])Oc4c([H])c([H])c(C([H])([H])O[H])c([H])c4[H])O [H])O[H])c([H])c([H])c1O[H]
TCMBANKIN044166 Cucurbitoside A C26H32O12 537 c1([H])c([H])c(C(=O)OC([H])([H])[C@@]2([C@]([H])([C@@]([H])(OC2([H])[H])O[C@]([H])([C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O3)[C@]3([H])Oc4c([H])c([H])c(C([H])([H])C([H])([H])O[H])c( [H])c4[H])O[H])O[H])c([H])c([H])c1[H]
TCMBANKIN046784 trans-Fagaramide 247.29 g/mol
TCMBANKIN048969 Cucurbitoside C C25H30O12 522 c1([H])c([H])c(C(=O)OC([H])([H])[C@@]2([C@]([H])([C@@]([H])(OC2([H])[H])O[C@]([H])([C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O3)[C@]3([H])Oc4c([H])c([H])c(C([H])([H])O[H])c([H])c4[H])O [H])O[H])c([H])c([H])c1[H]
TCMBANKIN058175 hydroxyresveratrol 2,4,3',5'-Tetrahydroxystilbene; oxyresveratrol ; Cudranin; oxyresveratrol; 2,3',4,5'-tetrahydroxystilbene; trans-2,3',4,5'-tetrahydroxystilbene; TETRAHYDROXYSTILBENE; Puag-haad; ACon1_001063; 1,3-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, (E)-; 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,3-diol; NSC 315550; 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol; 4-[2-(3,5-dihydroxyphenyl)vinyl]resorcinol; Oxyresveratrol; cudranin; C10273; 1,3-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-; MEGxp0_001057; 4-[2-(3,5-dihydroxyphenyl)vinyl]benzene-1,3-diol; 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]resorcinol; NSC315550; 4-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol; 4721-07-7; 29700-22-9 C14H12O4 244.24 g/mol C1=CC(=C(C=C1O)O)C=CC2=CC(=CC(=C2)O)O
TCMBANKIN058494 cucurbitoside b C26H32O13 552.5 g/mol C1C(C(C(O1)OC2C(C(C(OC2OC3=CC=C(C=C3)CCO)CO)O)O)O)(COC(=O)C4=CC=C(C=C4)O)O
TCMBANKIN058642 cucurbitine 3-Pyrrolidinecarboxylicacid, 3-amino-, (3S)-; (3R)-3-amino-3-pyrrolidinecarboxylic acid; AJ-76966; (3R)-3-aminopyrrolidine-3-carboxylic acid; EN300-86270; AC1Q4UAC; Cucurbitine; (S)-3-Aminopyrrolidine-3-carboxylic acid; (3S)-(?)-Cucurbitine; J-002967; 113473-30-6; BG00900626; 3-Pyrrolidinecarboxylic acid, 3-amino-, (R)-; (S)-(-)-Cucurbitine; 6807-92-7; Z2135; AK433912; 3-Pyrrolidinecarboxylic acid, 3-amino-, (3S)- (9CI); FCH932429; ZINC20286389; C10140; CTK0H2942; AKOS006237198; (3S)-3-aminopyrrolidine-3-carboxylic acid;pumpkin;cucurbitin C5H10N2O2 130.15 g/mol C1CNCC1(C(=O)O)N
TCMBANKIN060868 trans-2,4-decadienal C10H16O 152.23 g/mol CCCCCC=CC=CC=O
TCMBANKIN060879 Linolic acid C18H32O2 280.4 g/mol CCCCCC=CCC=CCCCCCCCC(=O)O
TCMBANKIN060910 cis-9-hexadecenoic acid C16H30O2 254.41 g/mol CCCCCCC=CCCCCCCCC(=O)O
TCMBANKIN060914 11-Octadecenoic acid C18H34O2 282.5 g/mol CCCCCCC=CCCCCCCCCCC(=O)O
TCMBANKIN060934 dec-2-enal C10H18O 154.25g/mol CCCCCCCC=CC=O
TCMBANKIN060958 oleic acid;cis-oleic acid;oleinic acid C18H34O2 282.46 CCCCCCCCC=CCCCCCCCC(=O)O
TCMBANKIN060966 gondoic acid C20H38O2 310.5 g/mol CCCCCCCCC=CCCCCCCCCCC(=O)O
TCMBANKIN061029 myristic acid C14H28O2 228.37 CCCCCCCCCCCCCC(=O)O
TCMBANKIN061045 PENTADECYLIC ACID C15H30O2 242.4 g/mol CCCCCCCCCCCCCCC(=O)O
TCMBANKIN061061 Hexadecanamide C16H33NO 255.44 g/mol CCCCCCCCCCCCCCCC(=O)N
TCMBANKIN061091 stearic acid CH3(CH2)16COOH 284.5 g/mol CCCCCCCCCCCCCCCCCC(=O)O
TCMBANKIN061105 Eicosanoic acid C20H40O2 312.53 g/mol CCCCCCCCCCCCCCCCCCCC(=O)O
TCMBANKIN061118 behenic acid C22H44O2 340.6 g/mol CCCCCCCCCCCCCCCCCCCCCC(=O)O
TCMBANKIN061128 n-tetracosanoic acid C24H48O2 368.64 g/mol CCCCCCCCCCCCCCCCCCCCCCCC(=O)O
TCMBANKIN061132 PENTACOSANOIC ACID;n-pentacosanoicacid C25H50O2 382.7 g/mol CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O
TCMBANKIN061134 Hexacosanoic acid C26H52O2 396.7 g/mol CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O
   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献
   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇ICP备16009434号-1 | Dai SX Lab